Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.3M Buy
+1,000,000
New +$17.8M ﹤0.01% 2904
2024
Q4
Sell
-116,000
Closed -$2.08M 10483
2024
Q3
$2.08M Hold
116,000
﹤0.01% 3949
2024
Q2
$2.04M Buy
+116,000
New +$2.4M ﹤0.01% 3755
2022
Q1
Sell
-74
Closed -$2K 10988
2021
Q4
$2K Buy
+74
New +$2.41K ﹤0.01% 9840
2021
Q2
Sell
-433,739
Closed -$16.3M 9884
2021
Q1
$16.3M Buy
+433,739
New +$18.5M 0.01% 1576

Other funds holding XP

UBS Group's XP Position: Q2 2026 in Review

UBS Group increased its XP (XP) stake by 17% in Q2 2026, buying an estimated $4.48M and bringing the position to 1,724,803 shares worth $28M. The position accounts for ﹤0.01% of the portfolio, ranked #2332.

UBS Group first reported a position in XP in Q4 2019 and has held it in 27 quarters since. The position peaked at $28.1M in Q1 2026. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • UBS Group held 1,724,803 shares of XP worth $28M as of Q2 2026.
  • UBS Group bought 251,295 XP shares in Q2 2026, an estimated $4.48M.
  • XP made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2332 holding.
  • UBS Group first reported a position in XP in Q4 2019 and has held it in 27 quarters since.
  • UBS Group's XP position peaked at $28.1M in Q1 2026.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.